BMS Revenue Slips Due to Revlimid Erosion: Q3 2023 Insights
Bristol Myers Squibb (BMS; NYSE: BMY) reported a 3% year-on-year (YOY) revenue decline, excluding foreign...
Finance
Sonosemi Medical Secures Over USD 27.3 Million in Series B Funding for Vascular Intervention Devices
Sonosemi Medical Co., Ltd., a Shenzhen-based innovator in vascular graft intervention devices, has reportedly secured...
Novartis Q3 Earnings Reflect Strong Growth Post-Sandoz Spinoff
Novartis (NYSE: NVS) has released its Q3 2023 financial results, marking the first report since...
Leadinno Medical Valley Secures Series A+ Funding for Neuroregulation Device R&D
Leadinno Medical Valley, a Beijing-based innovator in pain management and neuroregulation devices, has reportedly secured...
OrbiMed Raises Over USD 4.3 Billion for Private Investment Funds Focused on Healthcare
US-based investment fund giant OrbiMed has announced the successful raising of over USD 4.3 billion...
Changchun BCHT Biotechnology Invests in Influenza Vaccine Production Expansion
China-based Changchun BCHT Biotechnology Co., Ltd (SHA: 688276) has announced plans to invest RMB 805...
CBC HIP Secures USD 875 Million for Life Science Real Assets Venture CLSRA
CBC Healthcare Infrastructure Platform (CBC HIP), a prominent independent life science real assets investor in...
Roche’s Q3 2023 Report Shows 1% Global Growth Amid Lower COVID-19 Product Demand
Swiss pharmaceutical giant Roche (SWX: ROG) released its Q3 2023 report, indicating that a reduced...
AlphaGen Therapeutics Secures Seed Funding for Pb-212 Radioligand Therapy Development
AlphaGen Therapeutics Ltd, a Shanghai-based developer specializing in radioligand therapy (RLT), has reportedly secured “tens...
Pharmaron Beijing to Establish Singapore JV Rxilient Biohub for CDMO Services
China-based Contract Development and Manufacturing Organization (CDMO) Pharmaron Beijing Co., Ltd (HKG: 3759, SHE: 300759)...
Abbott Reports 8.7% Drop in Q3 2023 Global Sales, Hit by Lower SARS-CoV-2 Test Demand
Abbott (NYSE: ABT) published its Q3 2023 financial results this week, reporting a 8.7% year-on-year...
J&J Reports Strong Q3 2023 Sales Growth Amid Diverse Business Performance
Johnson & Johnson (J&J; NYSE: JNJ) has released its Q3 2023 report, revealing impressive global...
Sirius Therapeutics Secures USD 60 Million in Series B Financing for siRNA Therapy Development
Sirius Therapeutics, a Shanghai-based developer of siRNA therapies, has successfully raised USD 60 million in...
EpimAb Biotherapeutics Licenses Bispecific Antibody Platform to Almirall
Shanghai-based EpimAb Biotherapeutics has entered into a strategic license agreement with Spanish pharmaceutical company Almirall...
Suzhou Inhal Pharma Secures Series A Funding for Expansion and Clinical Advances
Suzhou Inhal Pharma Co., Ltd, a China-based company dedicated to the research and development of...
Atom Bioscience Secures $82M Series D to Advance Gout Treatment ABP-671
China-based Atom Bioscience, known formally as Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd, has reportedly...
Shanghai Pharma Health Commerce Secures $68M in Series C Funding Round
Shanghai Pharma Health Commerce Co., Ltd, a distinguished former subsidiary of China’s pharmaceutical giant Shanghai...
Novo Nordisk Reports 33% YOY Sales Increase, Boosts GLP-1 Drug Sales Forecast
Denmark-headquartered pharmaceutical giant Novo Nordisk (NYSE: NVO) provided a financial update last week, revealing a...
Pfizer Adjusts 2023 Revenue Projections Amidst Decreased COVID-19 Solution Demand
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has revised its projected 2023 revenues downward, reflecting a...
Sino Biopharmaceutical Sells 84.2% Stake in Shanghai CP General Pharmaceutical
China-based biotech company Sino Biopharmaceutical Ltd (HKG: 1177) has announced the sale of an 84.2%...